Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How should I account for the impact of ‘inflation’ on long-term operating costs in my financial planning?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q291 · Category F: Fees, budgeting and financial planning (Q251–Q300)
When undertaking long-term financial planning (for example, over 3 to 5 years), you must consider the impact of inflation; otherwise, your budget will soon become disconnected from reality. Inflation pushes up operating costs across the board, including staff salaries (employees will seek increases to offset the rising cost of living), rent (landlords may raise it on renewal), utility bills and the cost of some locally sourced materials. A simple and effective approach is to set a reasonable annual growth rate for operating expenses in your financial forecast for each future year, for example, by reference to Hong Kong’s average inflation rate over the past few years (usually around 2–3%), and increase the figures accordingly.

📘 Regulatory basis

Although no regulation directly requires you to include inflation in your budget, a robust, forward-looking financial plan is one of the implicit standards regulators use to assess whether you are a “fit and proper” licence holder and whether the company can “continue operating”.

📗 Drew Tang's recommendations

In addition to considering inflation on the cost side, you should also consider it on the revenue side. Does your pricing strategy have enough flexibility to adjust in response to rising costs? We recommend reviewing your pricing structure regularly to ensure that inflation does not continue to erode your profit margins.

📕 Risk notice

Ignoring the impact of inflation can lead to a substantial overestimate of your long-term profit projections. A business plan that appears profitable in its first year may be loss-making three to five years later as costs continue to rise. This is particularly risky for businesses that require long-term investment before returns are realised, such as pharmaceutical research and development.

Back to Category F: Fees, Budget and Financial Planning (Q251-Q300) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗